Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027
LONDON, August 3, 2017 /PRNewswire/ --
North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing
The global pharmaceutical contract manufacturing market was valued at $76.6bn in 2016 and is expected to grow at a CAGR of 6.6% in the first half of the forecast period. Between 2011 and 2016, the top 5 emerging market CMOs grew at a CAGR of 13.6%, whereas the leading developed market CMOs grew at a CAGR of 1.7% over the same period.
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you:
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 311-page report you will receive 184 tables and 111 figures - all unavailable elsewhere.
The 311-page report provides clear detailed insight into the pharmaceutical CMOs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope:
• Global Pharmaceutical Contract Manufacturing Market forecast from 2017-2027:
• API Manufacturing
• FDF Manufacturing
• Other Services
• This report profiles 30 leading CMOs in North America, Europe, Japan, China and India:
• Catalent
• Patheon
• Baxter
• AbbVie
• Pfizer
• Lonza
• Evonik Degussa
• Royal DSM
• Boehringer Ingelheim
• Fareva
• Aenova
• Famar
• Vetter
• Almac
• Delpharm
• Siegfried
• Corden
• Recipharm
• Aesica
• Nipro
• Daito
• Teva API
• Esteve Quimica
• Euticals
• Zhejiang Hisun Pharmaceuticals
• Zhejiang Huahai Pharmaceuticals
• Shandong Xinhua Pharmaceuticals
• Aurobindo Pharma
• Divis Laboratories
• Dr. Reddy's Laboratories
• The content of each profile differs, depending on the organisation. In general, a profile gives the following information:
• Overview of the company's contract manufacturing services and operations
• Analysis of recent financial performance - annual revenue for CMO services, including some data on operating profit and margins
• Assessment of developments - activities, acquisitions, production capacity, deals, new service offerings and collaborations
• SWOT analysis - a firm's strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth from 2016 onwards
• Forecasting of pharmaceutical manufacturing revenue to 2027, as well as projected operating profit and margin for some companies.
Visiongain's study is intended for anyone requiring commercial analyses for the top 30 pharmaceutical CMOs market. You find data, trends and predictions.
Buy our report today Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027: North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing.
To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100
Companies Mentioned in the Report:
Abbott Laboratories
Abic
AbbVie
Actavis
Adamas Pharmaceuticals
Aegerion
Aenova Group
Aesica Pharmaceuticals
Agennix
Aguettant
AlgoNomics
Alliance Medical Products
Almac Group
Alpharma
Amgen
AMYRA Biotech
Andeno
Apexigen
Aptuit
Archimica
Arecor
ArGEN-X
Astellas
AstraZeneca
Athera Biotechnologies
Aurobindo Pharma
Avalanche Biotechnologies
Banner Life Sciences
BaroFold
Barr-Pliva
BASF
Baxter BioPharma Solutions
Bayer
BC Partners
Becton and Dickinson (BD)
Beijing Double-Crane Pharmaceutical
Bentley
Biocraft
Biogal
Bionomics
Biotest
BioWa
Boehringer Ingelheim
Bridgepoint Capital
Bristol-Myers Squibb (BMS)
Britest
Canyon
Carbogen Amcis
Cardinal Health
Catalent
Celladon
Celldex Therapeutics
Celsion
CEVEC Pharmaceuticals
Chemtrix BV
China National Pharmaceutical Group (SInopharm)
Chirotech
Circadian Technologies
Cleveland BioLabs
Cobra Biomanufacturing
Companies House
CordenPharma
Corvette Pharmaceutical Services
Daiichi Sankyo
Daito
DecImmune Therapeutics
Delmas Perfusion
Delpharm
Divis Laboratories
DPx Holdings
Dr. Reddy's Laboratories
Dragenopharm Apotheker Püschl and Swiss Caps
Eclipse Therapeutics
Eisai
Eli Lilly
EmulTech
Esteve Química
Euro Vital Pharma
Euticals
Evonik Degussa
Excella
Exelixis
Famar
Fareva
Farmaprojects
Frazier Healthcare
Fuyang Xinghai Investment
Genentech
Genzyme
GSK
Corixa
Haupt Pharma
Health Canada
Hejiang Jiang Yuan Tang Biotechnology
Human Genome Sciences
ICI
Immune Pharmaceuticals
Immunomedics
Index Ventures
Indoco Remedies
Intellect Neurosciences
International Chemical Investors Group
Ivax API
JK Pharmaceutical
JLL Partners
Johnson & Johnson (J&J)
Kadmon
Laboratoires Besins
Lanxess Corporation
LBO Italia Investimenti s.r.l
Lonza
Marinopoulos Group.
MedImmune
Merck KGaA
Merck Serono
Mesoblast
Molecular Partners
Moody's Corporation
Mylan
Nipro Corporation
Novartis
Novasep
Novozymes
NPS
OctoPlus
OncoMed Pharmaceuticals
Opthea
Osiris Therapeutics
Otsuka Pharmaceutical
Pantec
Patheon
Perrigo
PFC
Pfizer
Pharmacia
Pharmacyclis
Pharmintraco
Piramal
Plantex
Poli Industria Chimica
Progenics Pharmaceuticals
Prosintex
R5 Pharmaceuticals
RAG AG
Ranbaxy Labs
Recipharm
Regeneus
Relthy Laboratórios
Relypsa
Respirics
Rexim
Roche
Royal DSM
Sandoz
Sanofi
Sanwa Kagaku Kenkyusho
Schering
ScinoPharm
Seattle Genetics
Sentry BioPharma Services
Servier
Shandong Tianda Biological Pharmaceutica
Shandong Xinhua Pharmaceutical
Shanghai Pharmaceutical
ShangPharma
Shire
Sicor
Siegfried
Sigmar Italia
Silverfleet Capital
Sinochem
SkyePharma
Solvay
Sun Pharma
Supernus Pharmaceuticals
SurModics
Swedbank
Swedish Orphan Biovitrium AB (Sobi)
Synkem
Syntex
Synthon
Takeda
Temmler Group
Tessenderlo Group
Teva Pharmaceutical Industries
Theramax
Tianjin Tianyo Pharmaceuticals
Tianma Tianji
Tunitas Therapeutics
UCB
UMN Pharma
UniQure
Vetter Pharma
Vidara
ViroPharma
Vivante GMP Solutions
VTU Technology
West Pharma
Wockhardt
XOMA
Yiwu Huayi Investment
Zhangjiang Biotech & Pharmaceutical Base Company
Zhejiang Hisun Pharmaceutical
Zhejiang Huahai Pharmaceuticals
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain Ltd
Share this article